The α4β7 blockade with vedolizumab is effective in prevention of graft vs. host disease using a xenogeneic mouse model.
Senthilnathan PalaniyandiReena KumariEthan StrattanTimothy HuangJing DuNatalya HakimMelissa V KeslerGerhard C HildebrandtPublished in: American journal of hematology (2019)